MedPath

Benzonatate

Benzonatate Capsules, USP 100 mg and 200 mg

Approved
Approval ID

ce85fa92-783e-4f71-b7ae-bc0eb0410e13

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 16, 2012

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Benzonatate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-078
Application NumberANDA040682
Product Classification
M
Marketing Category
C73584
G
Generic Name
Benzonatate
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 13, 2010
FDA Product Classification

INGREDIENTS (6)

BENZONATATEActive
Quantity: 100 mg in 1 1
Code: 5P4DHS6ENR
Classification: ACTIB
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
METHYLPARABEN SODIUMInactive
Code: CR6K9C2NHK
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
PROPYLPARABEN SODIUMInactive
Code: 625NNB0G9N
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Benzonatate - FDA Drug Approval Details